肺动脉高压-话题@MedSci

#肺动脉高压#

81篇内容 | 5104人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1050761, encodeId=06201050e612d, content=<a href='/topic/show?id=0bad820e112' target=_blank style='color:#2F92EE;'>#肺动脉高压#</a>这里是看长期的变化特点, objectTitle=Lancet Respir Med：肺动脉高压患者连续服用Selonsertib的疗效和安全性, objectType=article, longId=217067, objectId=4dc921e067d9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021913/1631544017378_2110107.JPG, objectUrl=/article/show_article.do?id=4dc921e067d9, replyNumber=0, likeNumber=143, createdTime=2021-09-14, rootId=0, userName=病毒猎手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4dc921e067d9, moduleTitle=Lancet Respir Med：肺动脉高压患者连续服用Selonsertib的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4dc921e067d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=950536, encodeId=e60b950536c1, content=<a href='/topic/show?id=0bad820e112' target=_blank style='color:#2F92EE;'>#肺动脉高压#</a>, objectTitle=JAHA：轻度升高的肺动脉压与肺动脉高压进展以及死亡率增加高风险相关, objectType=article, longId=208920, objectId=9c0d20892062, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021323/1616498519911_1739456.png, objectUrl=/article/show_article.do?id=9c0d20892062, replyNumber=0, likeNumber=184, createdTime=2021-03-23, rootId=0, userName=病毒猎手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c0d20892062, moduleTitle=JAHA：轻度升高的肺动脉压与肺动脉高压进展以及死亡率增加高风险相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c0d20892062)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=916634, encodeId=6b6991663483, content=<a href='/topic/show?id=70e8602218d' target=_blank style='color:#2F92EE;'>#曲前列尼尔#</a>吸入治疗<a href='/topic/show?id=14b99e293ea' target=_blank style='color:#2F92EE;'>#间质性肺炎#</a><a href='/topic/show?id=0bad820e112' target=_blank style='color:#2F92EE;'>#肺动脉高压#</a>，不过仍然只是治标的药物, objectTitle=NEJM：曲前列尼尔吸入治疗间质性肺炎肺动脉高压, objectType=article, longId=205732, objectId=eac7205e3264, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021112/1610409908680_1739456.jpg, objectUrl=/article/show_article.do?id=eac7205e3264, replyNumber=0, likeNumber=283, createdTime=2021-01-14, rootId=0, userName=lifefamily, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eac7205e3264, moduleTitle=NEJM：曲前列尼尔吸入治疗间质性肺炎肺动脉高压, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eac7205e3264)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=900098, encodeId=9c169000984c, content=<a href='/topic/show?id=ce9d239823b' target=_blank style='color:#2F92EE;'>#二甲双胍#</a>治疗<a href='/topic/show?id=0bad820e112' target=_blank style='color:#2F92EE;'>#肺动脉高压#</a>，算是<a href='/topic/show?id=9efb80281aa' target=_blank style='color:#2F92EE;'>#老药新用#</a>, objectTitle=JAHA：二甲双胍治疗肺动脉高压的II期临床试验, objectType=article, longId=203254, objectId=0697203254d7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201110/1605017989367_1739456.jpg, objectUrl=/article/show_article.do?id=0697203254d7, replyNumber=0, likeNumber=243, createdTime=2020-11-18, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0697203254d7, moduleTitle=JAHA：二甲双胍治疗肺动脉高压的II期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0697203254d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=898448, encodeId=3a198984485f, content=<a href='/topic/show?id=ce9d239823b' target=_blank style='color:#2F92EE;'>#二甲双胍#</a>对<a href='/topic/show?id=0bad820e112' target=_blank style='color:#2F92EE;'>#肺动脉高压#</a>PAH患者安全且耐受性良好，若再加上肺动脉高压治疗相关药物，疗效可能更好！！, objectTitle=JAHA：二甲双胍治疗肺动脉高压的II期临床试验, objectType=article, longId=203254, objectId=0697203254d7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201110/1605017989367_1739456.jpg, objectUrl=/article/show_article.do?id=0697203254d7, replyNumber=0, likeNumber=203, createdTime=2020-11-11, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0697203254d7, moduleTitle=JAHA：二甲双胍治疗肺动脉高压的II期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0697203254d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=888802, encodeId=cf7a8888026e, content=<a href='/topic/show?id=0bad820e112' target=_blank style='color:#2F92EE;'>#肺动脉高压#</a>, objectTitle=Circulation：MDM2介导的ACE2泛素化促进肺动脉高压进展, objectType=article, longId=201066, objectId=306b201066b9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020922/1600762352530_2467676.PNG, objectUrl=/article/show_article.do?id=306b201066b9, replyNumber=0, likeNumber=184, createdTime=2020-09-27, rootId=0, userName=Nebula-Qin, userId=74c72110107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=306b201066b9, moduleTitle=Circulation：MDM2介导的ACE2泛素化促进肺动脉高压进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=306b201066b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=803614, encodeId=8a7680361469, content=<a href='/topic/show?id=0bad820e112' target=_blank style='color:#2F92EE;'>#肺动脉高压#</a>不罕见的罕见病, objectTitle=陈玉成：中国肺动脉高压治疗现状与进展, objectType=video, longId=4249, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://medsci-video.oss-cn-shanghai.aliyuncs.com/upload/content/day_181105/big/201811052145202248.png, objectUrl=null, replyNumber=0, likeNumber=153, createdTime=2020-07-21, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72fd974249802, moduleTitle=陈玉成：中国肺动脉高压治疗现状与进展, moduleType=video, hrefUrl=)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=799902, encodeId=6406e9990288, content=<a href='/topic/show?id=0bad820e112' target=_blank style='color:#2F92EE;'>#肺动脉高压#</a>不罕见的罕见病！🌴🌴🌴, objectTitle=肺动脉高压该怎么用药？阜外医院经验, objectType=article, longId=196541, objectId=3fec19654190, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020626/1593105714791_5295922.jpg, objectUrl=/article/show_article.do?id=3fec19654190, replyNumber=0, likeNumber=223, createdTime=2020-06-26, rootId=0, userName=mswert122, userId=2a791737770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3fec19654190, moduleTitle=肺动脉高压该怎么用药？阜外医院经验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3fec19654190)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=601573, encodeId=ba386015e393, content=<a href='/topic/show?id=0bad820e112' target=_blank style='color:#2F92EE;'>#肺动脉高压#</a>蓝嘴唇的问题将逐步解决，肺动脉高压为罕见病，其实会转变为常见病，以前很多患者没有得到正确的诊断。, objectTitle=OCC 2020丨谁能拯救“蓝嘴唇”？肺动脉高压辩论会精彩角逐, objectType=article, longId=195379, objectId=13961953e988, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20200604/112914a0ba26499c8fb28b58a8a18c4e.jpg, objectUrl=/article/show_article.do?id=13961953e988, replyNumber=0, likeNumber=203, createdTime=2020-06-06, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13961953e988, moduleTitle=OCC 2020丨谁能拯救“蓝嘴唇”？肺动脉高压辩论会精彩角逐, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13961953e988)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=601572, encodeId=10406015e2ac, content=<a href='/topic/show?id=0bad820e112' target=_blank style='color:#2F92EE;'>#肺动脉高压#</a>最近几年，肺动脉高压领域的创新要非常多，未来相信会做得越来越好。, objectTitle=OCC 2020丨谁能拯救“蓝嘴唇”？肺动脉高压辩论会精彩角逐, objectType=article, longId=195379, objectId=13961953e988, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20200604/112914a0ba26499c8fb28b58a8a18c4e.jpg, objectUrl=/article/show_article.do?id=13961953e988, replyNumber=0, likeNumber=208, createdTime=2020-06-06, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13961953e988, moduleTitle=OCC 2020丨谁能拯救“蓝嘴唇”？肺动脉高压辩论会精彩角逐, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13961953e988)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

蓝嘴唇病，可能更多人知晓

2020-05-29

病毒猎手 (审核中...)

前往app查看评论内容

#肺动脉高压#这里是看长期的变化特点

Lancet Respir Med：肺动脉高压患者连续服用Selonsertib的疗效和安全性

2021-09-14

病毒猎手 (审核中...)

前往app查看评论内容

#肺动脉高压#

JAHA：轻度升高的肺动脉压与肺动脉高压进展以及死亡率增加高风险相关

2021-03-23

lifefamily (审核中...)

前往app查看评论内容

#曲前列尼尔#吸入治疗#间质性肺炎##肺动脉高压#，不过仍然只是治标的药物

NEJM：曲前列尼尔吸入治疗间质性肺炎肺动脉高压

2021-01-14

lovetcm (审核中...)

前往app查看评论内容

#二甲双胍#治疗#肺动脉高压#，算是#老药新用#

JAHA：二甲双胍治疗肺动脉高压的II期临床试验

2020-11-18

lovetcm (审核中...)

前往app查看评论内容

#二甲双胍#对#肺动脉高压#PAH患者安全且耐受性良好，若再加上肺动脉高压治疗相关药物，疗效可能更好！！

JAHA：二甲双胍治疗肺动脉高压的II期临床试验

2020-11-11

Nebula-Qin (审核中...)

前往app查看评论内容

#肺动脉高压#

Circulation：MDM2介导的ACE2泛素化促进肺动脉高压进展

2020-09-27

lovetcm (审核中...)

前往app查看评论内容

#肺动脉高压#不罕见的罕见病

陈玉成：中国肺动脉高压治疗现状与进展

2020-07-21

(审核中...)

前往app查看评论内容

#肺动脉高压#不罕见的罕见病！🌴🌴🌴

肺动脉高压该怎么用药？阜外医院经验

2020-06-26

lovetcm (审核中...)

前往app查看评论内容

#肺动脉高压#蓝嘴唇的问题将逐步解决，肺动脉高压为罕见病，其实会转变为常见病，以前很多患者没有得到正确的诊断。

OCC 2020丨谁能拯救“蓝嘴唇”？肺动脉高压辩论会精彩角逐

2020-06-06

lovetcm (审核中...)

前往app查看评论内容

#肺动脉高压#最近几年，肺动脉高压领域的创新要非常多，未来相信会做得越来越好。

OCC 2020丨谁能拯救“蓝嘴唇”？肺动脉高压辩论会精彩角逐

2020-06-06

科室
- - 订阅+
  - 更多科室
工具
服务